Long‐Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response

Documenti analoghi

• Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long‐term outcomes
  di: Eymen Pınar, et al.
  Pubblicazione: (2025)
• Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis
  di: Natalja Bouwhuis, et al.
  Pubblicazione: (2026)
• Effectiveness of Psychosocial Interventions on Stress, Anxiety, Depression, and Quality of Life in Parents of Children, Adolescents, and Young Adults With Cancer: A Meta‐Analysis of RCTs
  di: Cigdem Sari Ozturk, et al.
  Pubblicazione: (2025)
• Never Late: Cerebrotendinous Xanthomatosis and Improvements in Neurocognitive Functions in an Adult Patient on Chenodeoxycholic Acid Treatment
  di: Randa Sultan, et al.
  Pubblicazione: (2025)
• The Role of Digital Transformation in Women's Employment
  di: Yılmaz, Emine
  Pubblicazione: (2025)